Bio-Path Holdings Current Ratio 2009-2019 | BPTH

Bio-Path Holdings current ratio from 2009 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Bio-Path Holdings Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-09-30 $0.02B $0.00B 13.85
2019-06-30 $0.02B $0.00B 18.01
2019-03-31 $0.02B $0.00B 18.68
2018-12-31 $0.00B $0.00B 1.61
2018-09-30 $0.00B $0.00B 2.95
2018-06-30 $0.01B $0.00B 4.49
2018-03-31 $0.01B $0.00B 6.32
2017-12-31 $0.01B $0.00B 9.40
2017-09-30 $0.01B $0.00B 7.55
2017-06-30 $0.01B $0.00B 13.52
2017-03-31 $0.01B $0.00B 11.78
2016-12-31 $0.01B $0.00B 10.15
2016-09-30 $0.01B $0.00B 14.33
2016-06-30 $0.01B $0.00B 7.48
2016-03-31 $0.01B $0.00B 8.70
2015-12-31 $0.01B $0.00B 10.24
2015-09-30 $0.01B $0.00B 21.74
2015-06-30 $0.01B $0.00B 17.38
2015-03-31 $0.01B $0.00B 20.99
2014-12-31 $0.01B $0.00B 25.11
2014-09-30 $0.02B $0.00B 52.71
2014-06-30 $0.02B $0.00B 48.08
2014-03-31 $0.02B $0.00B 41.02
2013-12-31 $0.00B $0.00B 12.44
2013-09-30 $0.00B $0.00B 24.74
2013-06-30 $0.00B $0.00B 8.41
2013-03-31 $0.00B $0.00B 1.51
2012-12-31 $0.00B $0.00B 2.34
2012-09-30 $0.00B $0.00B 1.70
2012-06-30 $0.00B $0.00B 2.08
2012-03-31 $0.00B $0.00B 2.65
2011-12-31 $0.00B $0.00B 3.65
2011-09-30 $0.00B $0.00B 5.05
2011-06-30 $0.00B $0.00B 5.74
2011-03-31 $0.00B $0.00B 4.35
2010-12-31 $0.00B $0.00B 2.61
2010-09-30 $0.00B $0.00B 10.36
2010-06-30 $0.00B $0.00B 3.18
2010-03-31 $0.00B $0.00B 3.56
2009-12-31 $0.00B $0.00B 4.72
2009-09-30 $0.00B $0.00B 3.85
2009-06-30 $0.00B $0.00B 5.06
2009-03-31 $0.00B $0.00B 5.34
2008-12-31 $0.00B $0.00B 5.75
2008-09-30 $0.00B $0.00B 1244.88
2008-06-30 $0.00B $0.00B 331.43
2008-03-31 $0.00B $0.00B 253.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.022B $0.000B
BIO-PATH is developing leading-edge, patented, liposomal drug delivery systems, with two clinical cancer drug candidates ready for the clinic and a third siRNA cancer drug undergoing final pre-clinical development. Bio-Path's drug delivery technology distributes nucleic acid drugs systemically, throughout the human body, via simple intravenous infusion. The delivery technology can be applied both to double stranded and single stranded nucleic acid compounds with the potential to revolutionize the treatment of cancer and other diseases where drugable targets of disease are well characterized.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $62.561B 9.89
Zoetis (ZTS) United States $58.852B 35.20
Astellas Pharma (ALPMY) Japan $32.261B 16.11
Eisai (ESALY) Japan $20.942B 40.38
Grifols, S.A (GRFS) Spain $15.594B 20.43
UCB SA (UCBJF) Belgium $15.483B 0.00
Merck (MKGAF) Germany $14.630B 19.97
Neurocrine Biosciences (NBIX) United States $10.430B 492.39
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Ionis Pharmaceuticals (IONS) United States $8.678B 17.58
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.380B 10.70
Catalent (CTLT) United States $7.634B 31.06
IPSEN SA ADR (IPSEY) France $7.374B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $6.529B 98.87
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.226B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $4.932B 17.73
FibroGen (FGEN) United States $4.127B 121.28
United Therapeutics (UTHR) United States $4.059B 0.00
Nektar Therapeutics (NKTR) United States $3.800B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.641B 13.31
Sage Therapeutics (SAGE) United States $3.558B 0.00
Evotec AG (EVTCY) Germany $3.498B 57.24
PTC Therapeutics (PTCT) United States $2.966B 0.00
ArQule (ARQL) United States $2.439B 0.00
Heron Therapeutics (HRTX) United States $2.304B 0.00
Xencor (XNCR) United States $2.160B 65.65
Portola Pharmaceuticals (PTLA) United States $2.113B 0.00
Zogenix (ZGNX) United States $2.093B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.943B 61.95
Pacira Pharmaceuticals (PCRX) United States $1.900B 56.22
Tilray (TLRY) Canada $1.829B 0.00
ChemoCentryx (CCXI) United States $1.812B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.741B 0.00
USANA Health Sciences (USNA) United States $1.621B 17.30
Corcept Therapeutics (CORT) United States $1.551B 18.85
Enanta Pharmaceuticals (ENTA) United States $1.268B 28.95
CLINIGEN GP (CLIGF) United Kingdom $1.245B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.176B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.130B 0.00
Karyopharm Therapeutics (KPTI) United States $1.049B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.041B 7.10
Radius Health (RDUS) United States $1.019B 0.00
Endo (ENDP) Ireland $0.996B 1.83
Aerie Pharmaceuticals (AERI) United States $0.993B 0.00
Flexion Therapeutics (FLXN) United States $0.794B 0.00
Akebia Therapeutics (AKBA) United States $0.747B 0.00
Collegium Pharmaceutical (COLL) United States $0.684B 0.00
TherapeuticsMD (TXMD) United States $0.643B 0.00
Dermira (DERM) United States $0.636B 0.00
ImmunoGen (IMGN) United States $0.545B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.530B 0.00
Translate Bio (TBIO) United States $0.508B 0.00
Ardelyx (ARDX) United States $0.472B 0.00
Organogenesis Holdings (ORGO) United States $0.461B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.443B 53.75
Aptorum Group (APM) Hong Kong, SAR China $0.442B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.435B 18.74
Harpoon Therapeutics (HARP) United States $0.431B 0.00
Molecular Templates (MTEM) United States $0.412B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.410B 0.00
OptiNose (OPTN) United States $0.394B 0.00
Indivior (INVVY) United States $0.389B 1.41
Rigel Pharmaceuticals (RIGL) United States $0.382B 0.00
Siga Technologies (SIGA) United States $0.379B 8.65
Recro Pharma (REPH) United States $0.378B 0.00
DURECT (DRRX) United States $0.367B 0.00
Innate Pharma SA (IPHYF) France $0.358B 0.00
Lannett Co Inc (LCI) United States $0.354B 4.12
Corbus Pharmaceuticals Holdings (CRBP) United States $0.318B 0.00
Jounce Therapeutics (JNCE) United States $0.304B 4.06
Rafael Holdings (RFL) United States $0.303B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.285B 0.00
KalVista Pharmaceuticals (KALV) United States $0.276B 0.00
Concordia (CXRXF) Canada $0.269B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.267B 0.00
Calithera Biosciences (CALA) United States $0.243B 0.00
GlycoMimetics (GLYC) United States $0.242B 0.00
Xeris Pharmaceuticals (XERS) United States $0.241B 0.00
Aquestive Therapeutics (AQST) United States $0.193B 0.00
Ocular Therapeutix (OCUL) United States $0.192B 0.00
Nature's Sunshine Products (NATR) United States $0.191B 32.93
AcelRx Pharmaceuticals (ACRX) United States $0.190B 0.00
Concert Pharmaceuticals (CNCE) United States $0.188B 0.00
Taiwan Liposome (TLC) Taiwan $0.178B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.170B 0.00
IMV INC (IMV) Canada $0.157B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.146B 0.00
MEI Pharma (MEIP) United States $0.144B 0.00
Redhill Biopharma (RDHL) Israel $0.136B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.130B 0.00
CannTrust Holdings (CTST) Canada $0.116B 0.00
CV Sciences (CVSI) United States $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.094B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.088B 0.00
Capnia (SLNO) United States $0.084B 0.00
MediWound (MDWD) Israel $0.082B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.079B 23.64
Otonomy (OTIC) United States $0.077B 0.00
Champions Oncology (CSBR) United States $0.077B 0.00
Aclaris Therapeutics (ACRS) United States $0.075B 0.00
Neos Therapeutics (NEOS) United States $0.074B 0.00
PolarityTE (PTE) United States $0.073B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.071B 0.00
CTI BioPharma (CTIC) United States $0.070B 0.00
Infinity Pharmaceuticals (INFI) United States $0.067B 0.00
Nivalis Therapeutics (ALPN) United States $0.067B 0.00
Pharmaxis (PXSLY) Australia $0.065B 0.00
Forward Pharma (FWP) Denmark $0.065B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.063B 0.00
RENEURON GP (RNUGF) United Kingdom $0.062B 0.00
Genocea Biosciences (GNCA) United States $0.059B 0.00
Novan (NOVN) United States $0.059B 0.00
Natural Alternatives (NAII) United States $0.057B 14.29
Opiant Pharmaceuticals (OPNT) United States $0.057B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.056B 0.00
Medicure (MCUJF) Canada $0.055B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.053B 0.00
Mast Therapeutics (SVRA) United States $0.050B 0.00
AgeX Therapeutics (AGE) United States $0.049B 0.00
SCYNEXIS (SCYX) United States $0.046B 0.00
ElectroCore (ECOR) United States $0.046B 0.00
Iterum Therapeutics (ITRM) Ireland $0.044B 0.00
IsoRay (ISR) United States $0.042B 0.00
Opexa Therapeutics (ACER) United States $0.040B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.038B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.032B 0.00
Jaguar Animal Health (JAGX) United States $0.030B 0.00
PharmAthene (ALT) United States $0.028B 0.00
Shineco (TYHT) China $0.028B 0.00
India Globalization Capital (IGC) United States $0.027B 0.00
Biomerica (BMRA) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.026B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
Cardiome Pharma (CORV) Canada $0.023B 0.00
China SXT Pharmaceuticals (SXTC) China $0.022B 0.00
Melinta Therapeutics (MLNT) United States $0.022B 0.00
Heat Biologics (HTBX) United States $0.016B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Flex Pharma (SLRX) United States $0.015B 0.00
VAXART, INC (VXRT) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Vical (BBI) United States $0.013B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
Lipocine (LPCN) United States $0.009B 0.00
HANCOCK JAFFE (HJLI) United States $0.008B 0.00
Achieve Life Sciences (ACHV) United States $0.007B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Hemispherx BioPharma (AIM) United States $0.003B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00